Related Experiment Video
Updated: Feb 18, 2026

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
FOXO protects against age-progressive axonal degeneration
Inah Hwang1, Hwanhee Oh1, Evan Santo1
1Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Abstract:
Neurodegeneration resulting in cognitive and motor impairment is an inevitable consequence of aging. Little is known about the genetic regulation of this process despite its overriding importance in normal aging. Here, we identify the Forkhead Box O (FOXO) transcription factor 1, 3, and 4 isoforms as a guardian of neuronal integrity by inhibiting age-progressive axonal degeneration in mammals. FOXO expression progressively increased in aging human and mouse brains. The nervous system-specific deletion of Foxo transcription factors in mice accelerates aging-related axonal tract degeneration, which is followed by motor dysfunction. This accelerated neurodegeneration is accompanied by levels of white matter astrogliosis and microgliosis in middle-aged Foxo knockout mice that are typically only observed in very old wild-type mice and other aged mammals, including humans. Mechanistically, axonal degeneration in nerve-specific Foxo knockout mice is associated with elevated mTORC1 activity and accompanying proteotoxic stress due to decreased Sestrin3 expression. Inhibition of mTORC1 by rapamycin treatment mimics FOXO action and prevented axonal degeneration in Foxo knockout mice with accelerated nervous system aging. Defining this central role for FOXO in neuroprotection during mammalian aging offers an invaluable window into the aging process itself.
Insights
Forkhead Box O (FOXO) transcription factors protect neurons from aging-related degeneration. Inhibiting mTORC1 with rapamycin also prevents this decline, offering neuroprotection strategies for aging brains.
Area of Science:
- Neuroscience
- Genetics
- Aging Research
Background:
- Neurodegeneration, leading to cognitive and motor deficits, is a common aspect of aging.
- The genetic factors regulating age-related neurodegeneration are not well understood.
Purpose of the Study:
- To identify genetic regulators of age-related neurodegeneration.
- To investigate the role of Forkhead Box O (FOXO) transcription factors in maintaining neuronal integrity during aging.
Main Methods:
- Examined FOXO expression in aging human and mouse brains.
- Generated mice with nervous system-specific deletion of Foxo transcription factors.
- Assessed axonal degeneration, white matter gliosis, and mTORC1 activity.
- Administered rapamycin to inhibit mTORC1 in knockout mice.
Main Results:
- FOXO expression increased with age in mammalian brains.
- Nervous system-specific Foxo deletion accelerated axonal degeneration and motor dysfunction in mice.
- Accelerated degeneration in knockout mice showed increased astrogliosis and microgliosis.
- Axonal degeneration was linked to elevated mTORC1 activity and reduced Sestrin3 expression.
- Rapamycin treatment inhibited mTORC1, preventing axonal degeneration in knockout mice.
Conclusions:
- FOXO transcription factors act as guardians of neuronal integrity, inhibiting age-progressive axonal degeneration.
- FOXO-mediated neuroprotection during aging involves regulating mTORC1 activity and proteotoxic stress.
- Targeting FOXO pathways or mTORC1 may offer therapeutic strategies for age-related neurodegeneration.
Related Concept Videos
The Effect of Aging on Tissues
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Regulated Protein Degradation
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Neurogenesis and Regeneration of Nervous Tissue
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

